阿尔茨海默病和额颞叶痴呆的表观遗传学。
Epigenetics of Alzheimer's disease and frontotemporal dementia.
机构信息
Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA,
出版信息
Neurotherapeutics. 2013 Oct;10(4):709-21. doi: 10.1007/s13311-013-0219-0.
Abstract
This article will review the recent advances in the understanding of the role of epigenetic modifications and the promise of future epigenetic therapy in neurodegenerative dementias, including Alzheimer's disease and frontotemporal dementia.
摘要
本文将回顾近年来人们对表观遗传修饰作用的认识进展，以及未来在神经退行性痴呆（包括阿尔茨海默病和额颞叶痴呆）的表观遗传学治疗方面的前景。
相似文献
1
Epigenetics of Alzheimer's disease and frontotemporal dementia.
Neurotherapeutics. 2013 Oct;10(4):709-21. doi: 10.1007/s13311-013-0219-0.
2
Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.
J Alzheimers Dis. 2018;62(3):913-932. doi: 10.3233/JAD-170702.
3
Contemporary approaches to Alzheimer's disease and frontotemporal dementia.
Methods Mol Biol. 2011;670:1-9. doi: 10.1007/978-1-60761-744-0_1.
4
Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
J Alzheimers Dis. 2018;62(3):943-963. doi: 10.3233/JAD-170664.
5
Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines.
Int J Mol Sci. 2024 May 16;25(10):5445. doi: 10.3390/ijms25105445.
6
Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia.
Semin Neurol. 2020 Aug;40(4):394-410. doi: 10.1055/s-0040-1715134. Epub 2020 Aug 20.
7
Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia.
Expert Rev Neurother. 2018 Jun;18(6):469-475. doi: 10.1080/14737175.2018.1481389. Epub 2018 Jun 5.
8
Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia.
J Mol Neurosci. 2019 Jan;67(1):125-132. doi: 10.1007/s12031-018-1217-9. Epub 2018 Nov 22.
9
Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
Brain. 2023 Apr 19;146(4):1624-1636. doi: 10.1093/brain/awac362.
10
Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings.
Neurol Sci. 2010 Dec;31(6):741-9. doi: 10.1007/s10072-010-0400-8. Epub 2010 Sep 18.
引用本文的文献
1
Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.
Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.
2
Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis.
Front Mol Neurosci. 2024 Sep 3;17:1417961. doi: 10.3389/fnmol.2024.1417961. eCollection 2024.
3
Epigenetic clocks and their association with trajectories in perceived discrimination and depressive symptoms among US middle-aged and older adults.
Aging (Albany NY). 2022 Jul 1;14(13):5311-5344. doi: 10.18632/aging.204150.
4
Accelerated epigenetic age and cognitive decline among urban-dwelling adults.
Neurology. 2020 Feb 11;94(6):e613-e625. doi: 10.1212/WNL.0000000000008756. Epub 2019 Dec 26.
5
Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.
Neuromolecular Med. 2019 Sep;21(3):205-226. doi: 10.1007/s12017-019-08547-5. Epub 2019 May 21.
6
Formaldehyde, Epigenetics, and Alzheimer's Disease.
Chem Res Toxicol. 2019 May 20;32(5):820-830. doi: 10.1021/acs.chemrestox.9b00090. Epub 2019 Apr 19.
7
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS.
Sci Rep. 2017 Aug 21;7(1):8899. doi: 10.1038/s41598-017-09320-z.
8
Weighted Protein Interaction Network Analysis of Frontotemporal Dementia.
J Proteome Res. 2017 Feb 3;16(2):999-1013. doi: 10.1021/acs.jproteome.6b00934. Epub 2017 Jan 12.
9
A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer's disease patient leads to dementia and depression in mice.
Transl Psychiatry. 2016 Dec 6;6(12):e973. doi: 10.1038/tp.2016.237.
10
Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.
J Neurochem. 2017 Feb;140(3):383-394. doi: 10.1111/jnc.13912.
本文引用的文献
1
Clinical Toxicities of Histone Deacetylase Inhibitors.
Pharmaceuticals (Basel). 2010 Aug 26;3(9):2751-2767. doi: 10.3390/ph3092751.
2
Nanoparticles for brain drug delivery.
ISRN Biochem. 2013 May 21;2013:238428. doi: 10.1155/2013/238428. eCollection 2013.
3
Epigenetic drugs in Alzheimer's disease.
Biomol Concepts. 2013 Oct;4(5):433-45. doi: 10.1515/bmc-2013-0012.
4
Chromatin-bound RNA and the neurobiology of psychiatric disease.
Neuroscience. 2014 Apr 4;264:131-41. doi: 10.1016/j.neuroscience.2013.06.051. Epub 2013 Jul 3.
5
Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage.
Cytotechnology. 2014 May;66(3):449-55. doi: 10.1007/s10616-013-9597-8. Epub 2013 Jun 13.
6
Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion.
Am J Hum Genet. 2013 Jun 6;92(6):981-9. doi: 10.1016/j.ajhg.2013.04.017. Epub 2013 May 23.
7
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24.
8
Loss of histone deacetylase 2 improves working memory and accelerates extinction learning.
J Neurosci. 2013 Apr 10;33(15):6401-11. doi: 10.1523/JNEUROSCI.1001-12.2013.
9
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.
Onco Targets Ther. 2013;6:223-32. doi: 10.2147/OTT.S34680. Epub 2013 Mar 21.
10
Long noncoding RNAs in development and disease of the central nervous system.
Trends Genet. 2013 Aug;29(8):461-8. doi: 10.1016/j.tig.2013.03.002. Epub 2013 Apr 4.
Zotero 插件